Emcure Pharma IPO opens today: GMP rises; should you subscribe to the issue? CNBCTV18Namita Thapar-backed Emcure Pharma IPO opens for subscription. Should you bid? The Economic TimesNamita Thapar Will Get 293-Fold Return On Her Investment From This IPO NDTVEmcure Pharmaceuticals IPO opens today: GMP, subscription status, review, other details. Apply or not? | Stock Market News MintEmcure Pharma IPO: Namita Thapar’s investment could soar 293 times People Matters Emcure Pharma IPO opens today: GMP rises; should you subscribe to the issue? CNBCTV18Namita Thapar-backed Emcure Pharma IPO opens for subscription. Should you bid? The Economic TimesNamita Thapar Will Get 293-Fold Return On Her Investment From This IPO NDTVEmcure Pharmaceuticals IPO opens today: GMP, subscription status, review, other details. Apply or not? | Stock Market News MintEmcure Pharma IPO: Namita Thapar’s investment could soar 293 times People Matters Top stories – Google News